479
Views
15
CrossRef citations to date
0
Altmetric
Review

Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders

, , &
Pages 105-112 | Published online: 30 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Erika Ryst & Ann Childress. (2023) An updated safety review of the current drugs for managing ADHD in children. Expert Opinion on Drug Safety 22:11, pages 1025-1040.
Read now
Nicholas Cothros, Alex Medina & Tamara Pringsheim. (2020) Current pharmacotherapy for tic disorders. Expert Opinion on Pharmacotherapy 21:5, pages 567-580.
Read now

Articles from other publishers (13)

Narmada Mannem, Tejas Mehta, Elanagan Nagarajan, Naveen K. Yarasi & Pradeep C. Bollu. (2021) ADHD and Its Therapeutics. Current Developmental Disorders Reports 8:3, pages 175-183.
Crossref
Keisuke Ueda & Kevin J. Black. (2021) A Comprehensive Review of Tic Disorders in Children. Journal of Clinical Medicine 10:11, pages 2479.
Crossref
Sonja Eberl, Gabriele Ahne, Irmgard Toni, Joseph Standing & Antje Neubert. (2020) Safety of clonidine used for long‐term sedation in paediatric intensive care: A systematic review. British Journal of Clinical Pharmacology 87:3, pages 785-805.
Crossref
Sivapriya Vaidyanathan, Tess Maria Rajan, Venkatesh Chandrasekaran & Preeti Kandasamy. (2020) Pre-school attention deficit hyperactivity disorder: 12 weeks prospective study. Asian Journal of Psychiatry 48, pages 101903.
Crossref
Zhou Zhou, Keith A. Betts, Iryna Bocharova, David Kinrich & William M. Spalding. (2018) Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States. Journal of Attention Disorders 24:2, pages 336-347.
Crossref
Tori Czech, Reza Lalani & Moses O. Oyewumi. (2019) Delivery Systems as Vital Tools in Drug Repurposing. AAPS PharmSciTech 20:3.
Crossref
J. F. Pagel, Seithikurippu R. Pandi-Perumal & Jaime M. Monti. (2018) Treating insomnia with medications. Sleep Science and Practice 2:1.
Crossref
Charlotte Spay, Marion Albares, Guillaume Lio, Stephane Thobois, Emmanuel Broussolle, Brian Lau, Benedicte Ballanger & Philippe Boulinguez. (2018) Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining deep brain stimulation and electroencephalography recordings in Parkinsonian patients. Journal of Neurochemistry 146:3, pages 333-347.
Crossref
George Kapalka, Ronald T. Brown, David F. Curtis, Tony C. Wu & Mario Marquez. 2017. Cognitive Behavioral Psychopharmacology. Cognitive Behavioral Psychopharmacology 243 284 .
M S Breen, C H White, T Shekhtman, K Lin, D Looney, C H Woelk & J R Kelsoe. (2016) Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines. The Pharmacogenomics Journal 16:5, pages 446-453.
Crossref
Ming-Horng Tsai, Jen-Fu Hsu & Yu-Shu Huang. (2016) Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management. Current Psychiatry Reports 18:8.
Crossref
Keith A. BettsVanja SikiricaPaul HodgkinsZhou ZhouJipan XieAnthony DeLeonM. Haim ErderEric Q. Wu. (2014) Period Prevalence of Concomitant Psychotropic Medication Usage Among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder During 2009. Journal of Child and Adolescent Psychopharmacology 24:5, pages 260-268.
Crossref
Jose Martinez-Raga, Carlos Knecht, Nestor Szerman & María I. Martinez. (2012) Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder. CNS Drugs 27:1, pages 15-30.
Crossref